Adlai Nortye’s Post

Coming Up Next at the RegTech Digital Health Conference. Case study Presentation Topic: Innovative Digital Healthcare Solutions: Empowering Clinical and Pharmaceutical Research in Africa Speaker: Adriaan Kruger Kruger, Co-Founder & CEO, nuvoteQ.io Join here: https://lnkd.in/dnA7tRVt Don’t miss this engaging session as we dive into key insights and actionable strategies that are shaping the future of healthcare.

🌟CALLING ALL PHARMACEUTICAL PROFESSIONALS! Join us at the WOCIP Cluster Meetings, where collaboration sparks innovation! See the exciting topics covered in all four targeted business meetings below! Stay tuned as we unveil the unique topics for each day! Join forces with peers in your role across the industry to tackle barriers to health equity together! 🌎 REGISTER BY APRIL 12th AND GET 50% OFF. Use the link and code in the comments. #WOCIP #HealthEquity #PharmaIndustry

The mission to ensure equitable access to medication isn't just a moral duty—it's a commercial game-changer. As leaders, mastering communication with a broader patient base is crucial. Join our dynamic virtual panel discussion feauturing Stephen Framil (Corporate Global Head of Accessibility, Merck) Jill Pearcy (Director, Reputation, The Association of the British Pharmaceutical Industry (ABPI) Michelle Davey (CEO and Founder Davey, Wheel) Jenny Rudolph, MBA and Louis Savant, M.B.A. (Director Patient Access Transformation Strategies, Teva Pharmaceuticals) as we bridge the gap between market access and patient marketing. https://bit.ly/3YvpsSq Discover why making medication accessible and communicating it effectively is vital for meaningful impact. Don't miss out—be part of a conversation that matters! 💡 #HealthcareInnovation #PatientEngagement #MarketAccess

Prasanna Kumar Subbanna will be joining us at #TheMachinecon2024. He is a seasoned physician and business executive with over two decades of distinguished experience in the healthcare and pharmaceutical R&D sectors. With a profound understanding of the global value chain, his expertise spans clinical development, product launches, and bedside care, underscoring a comprehensive approach to healthcare innovation and patient outcomes. He will share his insights on "The Role of #GCCs in Healthcare Innovation" in an interesting panel Discussion. Novo Nordisk

 Excited to have participated in the esteemed "International Pharmaceutical Federation" webinar on "Working Together for the Future of Healthcare"! It was a fantastic opportunity to gain valuable insights into global trends shaping the healthcare landscape. Kudos to the speakers and organizers for such an enlightening session! Looking forward to applying these insights to enhance our collective efforts in advancing healthcare. #FIPWebinar #HealthcareTrends #Collaboration #PharmacyProfessionals

🌟"Redefining Value" in the Pharma Industry: Excited to have been part of the 𝟭𝘀𝘁 𝗦𝗙𝗘𝗘 𝗦𝘂𝗺𝗺𝗶𝘁🌟 Our Partner, Angelos Benos, Pharma & Healthcare Industry Lead at PwC Greece, took the stage yesterday at the 1st SFEE Summit, during an intriguing panel on “𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀 & 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗥&𝗗”💡Angelos contributed valuable insights and added depth to a discussion concerning investments of the Pharmaceutical sector in R&D and in particular Clinical Trials. Clinical trials represent a very significant Foreign Direct Investment pot that our country unfortunately has historically failed to claim its fair share and Angelos put forward certain policy initiatives that can help boost competitiveness and attract R&D investments by the Big-Pharma. #PwCGreece #SFEESummit2024 #HealthcareInnovation #GreekPharma

🔔 NEW EPISODE! Improving patient experience during clinical trials is undoubtedly one important opportunity for pharma to engage with patients better. But this is just scratching at the surface. There are SO MANY more opportunities for meaningful patient engagement in pharma, through and beyond the drug development process. On this episode, we talk to Bronwyn Lewis, Global Head of Patient Engagement at Boehringer Ingelheim. Drawing on her 20+ years of experience across diverse roles in the pharmaceutical industry, Bronwyn offers deep insights into how the industry is perceiving and responding to the call for deeper patient engagement, the challenges and opportunities for better multi-stakeholder collaboration, and her vision for the future. We found this conversation fascinating and energizing. We'd love for you to listen and let us know what you think! Website: https://lnkd.in/eit-Uj7T Spotify: https://lnkd.in/d9D3x4d8 Apple: https://lnkd.in/dpz5uGqn YouTube: https://lnkd.in/diVr2cbz #patientengagement #patientcentricity #pharmaceuticalindustry #patientadvocacy #drugdevelopment #patientexperience #patientempowerment #ClinicalTrialsDay #clinicaltrials

With double of the US population and universal healthcare access, Europe represents the second largest healthcare market in the world.    Today we bid farewell to our “Think about Europe” series of posts; through which we described the challenges and commercial opportunity that Europe represents for US-based pharmaceutical and biotech companies looking to expand their footprint.    The topics we have discussed during the campaign are linked here and outlined below >> https://lnkd.in/dtbB3CAM   Our overall recommendations to manufacturers are: A) Think about Europe early in the clinical development process to maximise the European opportunity, we recommend it to be no later than in Phase II clinical trials.    B) Understand country level reimbursement processes and pricing potential to help decision-makers think more intelligently about resource allocation in the long term    c) Consider engaging with an experienced partner for European market access to mitigate the potential commercialisation challenges down the road.   The Cogentia team are well prepared to help you identify potential pitfalls for the European market and bring much needed treatments to patients across Europe.    #marketaccess #europe #HEOR  

Meet the Panelists! At the 2024 Galien Forum, the "BioPharma Pressure Points: PBMs, Pricing, Access, and the Global Supply Chain" panel will convene leading experts to discuss critical issues shaping the pharmaceutical landscape. Zeke Emanuel: Vice Provost for Global Initiatives at the University of Pennsylvania, co-director of the Healthcare Transformation Institute, and a distinguished authority on healthcare policy. Ariel Katz: Co-founder and CEO of H1, specializing in healthcare data solutions to enhance global access to medical expertise. Dan Mendelson: CEO of Morgan Health at JPMorgan Chase & Co., focusing on innovative healthcare solutions and improving access to quality care. Dr. John O'Brien: President and CEO of the National Pharmaceutical Council, dedicated to advancing evidence-based healthcare policies. Dr. janet woodcock: Former Principal Deputy Commissioner of the U.S. FDA, with extensive experience in drug evaluation and research. This panel will delve into the complexities of pharmaceutical benefit management, pricing strategies, patient access, and the global supply chain, aiming to foster a more equitable and efficient healthcare system. #GalienForum2024 #PharmaPolicy #HealthcareAccess #GlobalHealth #PBM #DrugPricing #SupplyChain #HealthEquity

Wataru Momose, Ph.D., Director of Business Strategy, Otsuka Pharmaceutical Co Contributed an article "Insights into Healthcare Ecosystem" "In applying this mindset to disrupt the healthcare industry ecosystem, we can unite leaders from various industries, each with unique perspectives, while aligning with the shared goal of reducing medical costs and increasing healthy life expectancy." says Wataru Momose The article will also be featured in the forthcoming special print edition of Pharma Consulting 2024. Read More : https://lnkd.in/duzXQdeH #PharmaceuticalInnovation #HealthcareLeadership #CatalyticLeadership #HealthMonitoring #HealthcareEcosystem